Related Experiment Video
Updated: Jul 9, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?
M Schoppet1, R C Shroff, L C Hofbauer
1Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, UK.
Insights
Chronic kidney disease (CKD) accelerates vascular calcification by overwhelming inhibitors, damaging vascular cells, and altering mineral balance. Understanding circulating inhibitors may offer new strategies to prevent calcifying vasculopathies in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Chronic kidney disease (CKD) is linked to severe cardiovascular issues, primarily due to ectopic calcification in arteries, capillaries, and heart valves.
- Vascular calcification in CKD is a multifactorial process involving mineral imbalances (hyperphosphatemia, high calcium x phosphate product), deficient calcification inhibitors, vascular smooth muscle cell (VSMC) damage, and VSMC phenotypic transformation.
Purpose of the Study:
- To investigate the role of calcification inhibitors in CKD-associated vascular calcification.
- To explore the mechanisms and sites of action for identified calcification inhibitors.
- To determine if circulating inhibitors influence disease progression or indicate underlying pathologies in CKD patients.
Main Methods:
- Analysis of experimental studies and in vivo data.
- Studies involving genetically altered mice to identify calcification inhibitors.
- Investigation into the mechanisms of VSMC damage and cell death in CKD.
Main Results:
- CKD patients exhibit overwhelmed inhibitory systems, leading to VSMC damage and cell death.
- Vesicles released from damaged cells can nucleate basic calcium phosphate, promoting calcification.
- Genetically modified mouse models have identified local and systemic calcification inhibitors crucial for VSMC differentiation and vesicle regulation.
Conclusions:
- A deeper understanding of circulating calcification inhibitors' origins and functions is crucial.
- Identifying the roles of these inhibitors could lead to novel therapeutic strategies for CKD-related calcifying vasculopathies.
Abstract:
Chronic kidney disease (CKD) is associated with fatal cardiovascular consequences in part due to ectopic calcification of soft tissues particularly arteries, capillaries, and cardiac valves. An increasing body of evidence from experimental studies and in vivo data suggest that (I) a mineral imbalance with hyperphosphatemia and high-circulating calcium x phosphate product, (II) a deficiency of systemic or local calcification inhibitors, (III) death or 'damage' of vascular smooth muscle cells (VSMCs), and/or (IV) phenotypic transformation of VSMCs to osteo/chondrocytic cells may all act in concert to initiate and sustain vascular calcification. In CKD patients inhibitory systems are overwhelmed by a multitude of agents that induce VSMC damage and cell death resulting in the release of vesicles capable of nucleating basic calcium phosphate. Studies with genetically altered mice have identified both local and systemic calcification inhibitors that act to maintain VSMC differentiation or regulate vesicle properties. However, for many of these proteins the mechanisms and sites of action are still under investigation. In particular, it is unclear whether factors present in the circulation have an inhibitory role there and whether circulating levels of these proteins influence or are indicative of underlying disease processes in individual patients. A greater understanding of the origins and roles of potential circulating inhibitors may result in novel strategies aimed at the prevention or reversal of the life-limiting calcifying vasculopathies seen in CKD patients.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Skeleton and Calcium Homeostasis
Acute Kidney Injury II: Pathophysiology

